Elevated Plasma Fibronectin Levels in Rats with Immune and Toxic Glomerular Diseases

References

• Mosesson M W, Amrani D L. The structure and biologic activities of plasma fibronectin. Blood 1980; 56: 145–158
   PubMed Web of Science ®Google Scholar
• Saba T M, Jaffe E. Plasma fibronectin: Its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 1980; 68: 577–593
   PubMed Web of Science ®Google Scholar
• Pommier C G, Inada S, Fries L F, Takahashi T, Frank M M, Brown E J. Plasma fibronectin enhances phagotyctosis of opsonized particles by human peripheral blood monocytes. J Exp Med 1983; 157: 1844–1854
   PubMed Web of Science ®Google Scholar
• Eriksen H O, Kalaja E, Jensen B A, Clemmemsen I. Plasma fibronectin concentrations in patients with severe burn injury. Burns 1984; 10: 422–426
   Web of Science ®Google Scholar
• Mosher D F, Williams E M. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 1978; 91: 729–735
   PubMed Web of Science ®Google Scholar
• Saba TM. Plasma and tissue fibronectin: Its role in the patho-physiology of the critically ill septic injured patient. Critical Care, State of the Art, B Chernow, WC Shoemaker. Society of Critical Care Medicine, California 1986; Vol 7: pp 437–464
   Google Scholar
• Todd T R, Glynn MFX, Silver E, Redmond M D. A randomized trial of cryoprecipitate replacement of fibronectin deficiencies in the critically ill. Am Rev Resp Dis 1984; 129: A102
   Google Scholar
• Cooper S M, Keyser A J, Bearliev A D, Ruoslahti E, Nimni M E, Quismorio FPL. Increase in fibronectin in deep dermis of involved skin in progressive systemic sclerosis. Arthr Rheum 1979; 22: 983–987
   PubMedGoogle Scholar
• Carsons S, Mosesson M W, Diamond H S. Detection and quan-titation of fibronectin in synovia] fluid from patients with rheumatic disease. Arthr Rheum 1981; 24: 1261–1267
   PubMedGoogle Scholar
• Herbert K E, Coppock J S, Griffiths A M, Williams A, Robinson M W, Scott D L. Fibronectin and immune complexes in rheumatic diseases. Ann Rheum Dis 1987; 46: 734–740
   PubMed Web of Science ®Google Scholar
• Cosio F G, Bakaletz A P. Abnormal plasma fibronectin levels in patients with proteinuria. J Lab Clin Med 1984; 104: 867–872
   PubMed Web of Science ®Google Scholar
• Sánchez Crespo M, Alonso F, Barat A, Egido J. Rat serum sickness: possible role of inflammatory mediators allowing deposition of immune complexes in the glomeralar basement membrane. Clin Exp Immunol 1982; 49: 631–638
   PubMed Web of Science ®Google Scholar
• Vuento M, Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 1979; 183: 331–337
   PubMed Web of Science ®Google Scholar
• Weber K, Osborn M. The reliability of molecular weight determinations by dodecylsulphatepolyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406–4412
   PubMed Web of Science ®Google Scholar
• Mosesson M W, Chen A B, Huseby R M. The cold-insoluble globulin of human plasma studies of its essential structural features. Biochem Biophys Acta 1975; 386: 509–524
   PubMedGoogle Scholar
• Laurell CB. Electroimmunoassay. Scand J Lab Inves 1972; 29(SuppI. 124)21–37
   Google Scholar
• Quirós J, Gonzalez-Cabrero J, Herrero-Beaumont G, Egido J. Beneficial effect of fibronectin administration on chronic nephritis in rats. Arthr Rheum 1990; 33: 685–692
   PubMedGoogle Scholar
• Krieg T H, Hein R, Hatamochi A, Aumailley M. Molecular and clinical aspects of connective tissue. Eur J Clin Invest 1988; 18: 105–123
   PubMed Web of Science ®Google Scholar
• Cosio F G, Bakaletz A P. Role of fibronectin on the clearance and tissue uptake of antigen immune complexes in rats. J Clin Invest 1987; 80: 1270–1279
   PubMed Web of Science ®Google Scholar
• Schena F P, Pertosa G. Fibronectin and Kidney. Nephron 1988; 48: 177–182
   PubMed Web of Science ®Google Scholar
• Zazgornik J, Graninger W, Minar E, Schmidt P, Balcke P, Haubenstock A, Kopsa H. Elevated plasma fibronectin levels in nephrotic syndrome. Klin Wochenschr 1984; 62: 531–532
   PubMedGoogle Scholar
• Tamkun J W, Hynes R O. Plasma Fibronectin is synthesized and secreted by hepatocytes. J Biol Chem 1983; 258: 4641–4647
   PubMed Web of Science ®Google Scholar
• Peters J H, Ginsberg M H, Bohl B P, Sklar L A, Cochrane C G. Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung. J Clin Invect 1986; 78: 1596–1603
   PubMed Web of Science ®Google Scholar
• Herrero-Beaumont G, Egido J, Sancho J, González E, Castañeda S, Escanero J F. Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells. Immunology 1988; 63: 87–92
   PubMed Web of Science ®Google Scholar
• Egido J, Robles A, Ortiz A, Ramirez F, González E, Mampaso F, Sánchez-Crespo M, Braquet P, Hernando L. Role ofplatelet-activating factor in adriamycin-induced nephropathy in rats. Eur J Pharmacol 1987; 138: 119–123
   PubMed Web of Science ®Google Scholar
• Schnaper H W, Robson A M. Nephrotic syndrome: minimal change disease, focal glomerulosclerosis, and related disorders. Diseases of the Kidney, RW Schrier, CW Gottschalk. Little, Brown, Boston/Toronto 1989; pp 1949–2004
   Google Scholar
• Hagiwara T, Kono I, Nemoto K, Kashiwagi H, Onozaki K. Recom-binant interleukin-1 triggers the increase of circulating fibronectin levels in rats. Int Arch Allergy Appl Immunol 1989; 89: 376–380
   PubMedGoogle Scholar
• Mosher D F, Williams E M. Fibronectin concentration is decrease in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 1978; 91: 729–735
   PubMed Web of Science ®Google Scholar
• Mosher DF. Physiology of fibronectin. Ann Rev Med 1984; 35: 561–575
   PubMed Web of Science ®Google Scholar
• Bohnsack J F, O'Shea J J, Takahashi T, Brown E J. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1). J Immunol 1985; 135: 2680–2686
   PubMed Web of Science ®Google Scholar
• Sorvillo J M, Gigli I, Pearlstein E. The effect of fibronectin on the processing of Clq-and C3b/bi-coated immune complexes by peripheral blood monocytes. J Immunol 1986; 136: 1023–1026
   PubMed Web of Science ®Google Scholar
• Wachtfogel Y T, Abrams W, Kucich U, Weinbaum G, Schapira M, Colman R W. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranula-tion. J Clin Inves 1988; 81: 1310–1316
   PubMed Web of Science ®Google Scholar
• Czop J K, Kadish J L, Austen K F. Augmentation of human monocyte opsonin-indpendent phagocytosis by fragments of human plasma fibronectin. Proc Natl Acad Sci USA 1981; 78: 3649–2653
   PubMed Web of Science ®Google Scholar
• Ehrlich M I, Krushell J S, Blumenstock F A, Kaplan J E. Depression of phagocytosis by plasmin degradation products of plasma fibronectin. J Lab Clin Med 1981; 98: 263–271
   PubMed Web of Science ®Google Scholar
• Rourke F J, Blumenstock F A, Kaplan J E. Effect of fibronectin fragments on macrophage phagocytosis of gelatinized particles. J Immunol 1984; 132: 1931–1936
   PubMed Web of Science ®Google Scholar
• Oh E, Pierschbacher M, Ruoslahti E. Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci USA 1981; 78: 3218–3221
   PubMed Web of Science ®Google Scholar